NanoViricides Inc
Research NanoViricides Inc (NNVC) on Bullrun: market cap USD 29.39M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNNVC
- ExchangeNYSE MKT
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 29.39M
- Financial periodQ1 2026
- RevenueUSD 0
- Net income-USD 1.99M
- Free cash flow-USD 1.93M
Valuation Snapshot
latest market cap is USD 29.39M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 9.47M | -USD 8.54M | n/a | -0.63 | USD 1.56M | n/a | USD 7.52M |
| FY2024 | USD 0 | -USD 8.29M | -USD 6.47M | n/a | -0.7 | USD 4.80M | n/a | USD 11.46M |
| FY2023 | USD 0 | -USD 8.59M | -USD 5.82M | n/a | -0.74 | USD 8.15M | USD 1.50M | USD 14.87M |
| FY2022 | USD 0 | -USD 8.11M | -USD 6.22M | n/a | -0.7 | USD 14.07M | USD 23.84K | USD 23.08M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 29.39M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 24.40M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 22.37M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 11.98M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 12.89M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 42.91M | n/a | n/a | n/a |
About NanoViricides Inc
NanoViricides, Inc., a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs to combat viral infections. The company's product portfolio includes NV-387 drug candidate developed for RSV and influenza indications and has completed phase 1a/1b human clinical trial for the evaluation of safety and tolerability;
Related stock research
Other Healthcare stocks
Adicet Bio Inc (1IJ)
Cartesian Therapeutics, Inc. (1S70)
QUOIN PHARMACEUT.ADR5000 (2EB0)
Aardvark Therapeutics Inc (AARD)
Abeona Therapeutics Inc (ABEO)
Acumen Pharmaceuticals Inc (ABOS)
Absci Corp (ABSI)
Arbutus Biopharma Corp (ABUS)
ABVC BioPharma Inc (ABVC)
Acadia Pharmaceuticals Inc (ACAD)
Adicet Bio Inc (ACET)
Achieve Life Sciences Inc (ACHV)
Frequently asked questions
What is NanoViricides Inc's market cap?
NanoViricides Inc's market capitalization is USD 29.39M.
What does NanoViricides Inc do?
NanoViricides, Inc., a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs to combat viral infections.